This
Season's
Flu
Virus
Is
Resistant
to
2 Standard
Drugs
Many
HIV
and
HIV
and
hepatitis
coinfected
patients
are
at
high
risk
for
influenza
each
year
due
to
their
compromised
immune
status.
The
US
Centers
for
Disease
Control
and
Prevention
(CDC)
recommends
that
all
HIV
positive
individuals,
especially
those
with
advanced
HIV
disease,
receive
the
influenza
vaccination
shot
annually.
In
2006,
the
CDC
has
issued
an
additional
important
advisory
regarding
medications
sometimes
used
to
treat
influenza:
Doctors
should
stop
prescribing
two
standard
antiviral
drugs
to
treat
or
prevent
this
season's
influenza
because
the
predominant
strain
has
quickly
become
resistant
to
them,
advise
federal
health
officials
The
standard
drugs
are
amantadine
and
rimantadine.
Instead,
the
Centers
for
Disease
Control
and
Prevention
(CDC)
recommends
that
doctors
prescribe
two
newer
antiviral
drugs,
oseltamivir
(Tamiflu)
and
zanamivir
(Relenza),
and
said
ample
supplies
were
available.
The
agency
also
urged
the
public
to
get
flu
shots.The
new
findings
concern
only
the
strain
of
influenza
causing
regular
seasonal
influenza,
and
not
avian
avian
influenza
or
pandemic
influenza,
said
the
centers'
director,
Dr.
Julie
L.
Gerberding.
Scientists
have
been
alarmed
about
a rising
incidence
of
drug
resistance
among
influenza
viruses
isolated
from
patients
around
the
world
over
the
last
decade
and
their
ability
to
be
transmitted
from
person
to
person. Globally,
the
incidence
rose
to
12.3
percent
in
the
2003-2004
season
from
0.4
percent
in
the
1994-1995
season,
the
C.D.C.
and
other
scientists
reported
in
The
Lancet
on
Oct.
1,
2005.
In
the
United
States,
the
incidence
of
such
resistance
has
soared
to
91
percent
from
1 percent. 01/17/06 Source R
Altman.
This
Season'
s Flu
Virus
Is
Resistant
to
2 Standard
Drugs.
January
15,
2006.
Link
to
Index
of
All
HIV
and
AIDS
Articles
by
Topic
|